COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,252 Articles (22,236 medRxiv, 8,016 bioRxiv)

Most recent first Previous |  Page 1073: Articles 10721-10730  | Next

Evidence of transmission from fully vaccinated individuals in a large outbreak of the SARS-CoV-2 Delta variant in Provincetown, Massachusetts
Siddle, K. J., Krasilnikova, L. A., Moreno, G. K., Schaffner, S. F., Vostok, J., Fitzgerald, N. A., Lemieux, J. E., Barkas, N., Loreth, C., Specht, I., Tomkins-Tinch, C. H., Silbert, J., Schaeffer, B., Taylor, B. P., Loftness, B., Johnson, H., Schubert, P. L., Shephard, H. M., Doucette, M., Fink, T., Lang, A. S., Baez, S., Beauchamp, J., Hennigan, S., Buzby, E., Ash, S., Brown, J., Clancy, S., Cofsky, S., Gagne, L., Hall, J., Harrington, R., Gionet, G. L., DeRuff, K. C., Vodzak, M. E., Adams, G. C., Dobbins, S. T., Slack, S. D., Reilly, S. K., Anderson, L. M., Cipicchio, M. C., DeFelice, M. T., Grimsby, J. L., Anderson, S. E., Blumenstiel, B. S., Meldrim, J. C., Rooke, H. M., Vicente, G., Smith, N. L., Messer, K. S., Reagan, F. L., Mandese, Z. M., Lee, M. D., Ray, M. C., Fisher, M. E., Ulcena, M. A., Nolet, C. M., English, S. E., Larkin, K. L., Vernest, K., Chaluvadi, S., Arvidson, D., Melchiono, M., Covell, T., Harik, V., Brock-Fisher, T., Dunn, M., Kearns, A., Hanage, W. P., Bernard, C., Philippakis, A., Lennon, N. J., Gabriel, S. B., Gallagher, G. R., Smole, S., Madoff, L. C., Brown, C. M., Park, D. J., MacInnis, B. L., Sabeti, P. C.
10.1101/2021.10.20.21265137 — Posted: 2021-10-20 Discussion: Onsite
Airborne transmission of SARS-CoV-2 over distances greater than two metres: a rapid systematic review
Palmer, J. C., Duval, D., Tudge, I., Sarfo-Annin, J. K., Pearce-Smith, N., O'Connell, E., Bennett, A., Clark, R.
10.1101/2021.10.19.21265208 — Posted: 2021-10-20
Mutations on non-structural proteins of SARS-CoV-2 are possibly responsible for adverse clinical outcomes in a real-life practice
Ichikawa, T., Torii, S., Suzuki, H., Takada, A., Suzuki, S., Nakajima, M., Tampo, A., kakinoki, y.
10.1101/2021.10.19.21265062 — Posted: 2021-10-20
Modeling brings additional insights into the kinetics of SARS-CoV-2 neutralizing antibody
Prague, M., Clairon, Q., Guedj, J., Thiebaut, R.
10.1101/2021.10.13.21264693 — Posted: 2021-10-20
SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021
Marques, A., Sherrill-Mix, S., Everett, J. K., Reddy, S., Hokama, P., Roche, A. M., Hwang, Y., Glascock, A., Whiteside, S. A., Graham-Wooten, J., Khatib, L. A., Fitzgerald, A. S., Moustafa, A., Bianco, C., Rajagopal, S., Helton, J., Deming, R., Denu, L., Azad, A., Kitt, E., Coffin, S., Newbern, C., Mell, J. C., Planet, P. J., Badjatia, N., Wang, Z.-X., Cannuscio, C. C., Strelau, K., Jaskowiak-Barr, A., Cressman, L., Loughrey, S., Ganguly, A., Feldman, M. D., Collman, R. G., Rodino, K. G., Kelly, B. J., Bushman, F. D.
10.1101/2021.10.18.21264623 — Posted: 2021-10-20
SARS-CoV-2 variant transmission in a community-health population (Mexico City, Mexico)
Zhang, W., Martinez, M., Davis, B. D., Chen, S. S., Sincuir Martinez, J., Corona, C., Diaz, G., Makhoul, E., Heneidi, S., Goldberg, J., Plummer, J. T., Vail, E.
10.1101/2021.10.18.21264783 — Posted: 2021-10-20
Longitudinal and comparative analysis of humoral response upon COVID-19 vaccination
Romero-Pinedo, S., Quesada, M., Alvarez-Fernandez, S., Olmo, A., Abia, D., Alarcon, B., Delgado, P.
10.1101/2021.10.14.21264762 — Posted: 2021-10-20
Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts
Collier, A.-r., Brown, C., McMahan, K., Yu, J., Liu, J., Jacob-Dolan, C., Chandrashekar, A., Tierney, D., Ansel, J., Rowe, M., Sellers, D., Ahmad, K., Aguayo, R., Anioke, T., Gardner, S., Siamatu, M., Bermudez Rivera, L., Hacker, M., Madoff, L., Barouch, D.
10.1101/2021.10.18.21265113 — Posted: 2021-10-20
One-dose ChAdOx1 nCoV-19 Vaccine Effectiveness Against Symptomatic COVID-19 in a vulnerable community in Rio de Janeiro, Brazil: test-negative design study
Ranzani, O. T., Silva, A. A. B., Peres, I. T., Antunes, B. B. P., Gonzaga-da-Silva, T. W., Soranz, D. R., Cerbino-Neto, J., Hamacher, S., Bozza, F. A.
10.1101/2021.10.16.21265095 — Posted: 2021-10-20
Survey of Direct and Indirect Effects of COVID-19 on Eyes and the Common Ocular Manifestations
Rabi, D., Rabi, r., Jarrar, A., Maharma, S., Jaradat, A., Bzoor, s.
10.1101/2021.10.18.21265130 — Posted: 2021-10-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).